European Medicines Agency approves abiraterone combined with hormone therapy as first-line treatment for advanced prostate cancer 22 Nov 2017
ASCO 2017: Adding abiraterone to standard treatment improves prostate cancer survival by almost 40% 03 Jun 2017
Counting cancer cells in blood could be key to telling whether prostate cancer treatment is working 14 Sep 2016